首页> 外文期刊>Nutrafoods >Metabolic disorders and cancer: is there a role for nutraceuticals?
【24h】

Metabolic disorders and cancer: is there a role for nutraceuticals?

机译:代谢障碍和癌症:营养保健品有作用吗?

获取原文
获取原文并翻译 | 示例
           

摘要

Obesity and overweight are defined as abnormal excess accumulation of fat in adipose tissue, which is recognized as a real organ with both metabolic and endocrine functions, and have a close relationship with oncological risk. The relationship betweenobesity and carcinogenesis is complex and not fully understood. However, obesity is frequently associated with several pathological states such as chronic inflammation, dyslipidaemia and insulin resistance (generally defined as metabolic disorders) which contribute to the increased risk of cancer in the overweight population. Current data show that metabolic disorders are often reversible with prompt therapeutic intervention, so these conditions and related carcinogenetic pathways should be managed forcancer prevention and therapy. Metformin and statins have demonstrated their ability to interfere with tumour processes but unfortunately also produce side effects, making long-term and preventative use difficult. Some nutraceutical compounds seem to beideal for providing similar activity and effectiveness as these agents but with minor or absent side effects. This review examines the pathophysiology of metabolic disorders, their relationship with cancer and the possibility of interfering with associated processes with some promising nutraceuticals used as monotherapy or in combination with conventional therapies.
机译:None

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号